NCT01150045: A trial that was reported late by Alliance for Clinical Trials in Oncology
This trial has reported, although it was 88 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01150045 |
|---|---|
| Title | A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 30, 2010 |
| Completion date | Feb. 28, 2020 |
| Required reporting date | Feb. 27, 2021, midnight |
| Actual reporting date | May 27, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 88 |